Recombinetics (United States)
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO. In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Recombinetics (United States), United States, covering academic research published from 2005 to 2023. Read More.
Open Access Percentage
77%
Total
Publications
176
Total Open
Publications
136
Total
Citations
6.3K
Open Access
Percentage
77%
Total
Publications
176
Total Open
Publications
136
Total
Citations
6.3K
Breakdown
Publisher Open
21%
Both
44%
Other Platform Open
12%
Closed
23%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
56
Hybrid 33%
38
No Guarantees 18%
21
Other Platform Open
Domain 87%
86
Institution 35%
35
Preprint 14%
14
Public 9%
9
Other Internet 8%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 85 |
Europe PMC | Domain | 49 |
bioRxiv | Preprint | 14 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 12 |
Semantic Scholar | Public | 7 |
Ecole Polytechnique Fédérale de Lausanne - Infoscience | Institution | 7 |
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna | Institution | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 5 |
iastate.edu OAI-PMH Repository | Institution | 5 |
University of California - eScholarship University of California | Institution | 4 |